Portfolio company
Cozart
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Cozart develops rapid saliva-based drug testing devices for use by police, healthcare professionals and transport organisations to detect substances of abuse on-site.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hound Labs
This company develops breathalyzers that detect recent cannabis use for employers and law enforcement agencies to maintain workplace safety and identify impairment.
Vigilant Biosciences
This company develops saliva-based point-of-care diagnostic tests for the early detection of oral cancer for clinicians and dental practices.
Spectra Plasmonics
This company develops portable chemical analysis sensors for law enforcement and public health agencies to identify unknown substances and narcotics in the field.
Upfront Diagnostics
The company develops rapid point-of-care blood tests for stroke identification, serving paramedics, emergency medical services, and hospital clinicians.
Orphan diagnostics
This company develops point-of-care bedside tests to detect methanol poisoning for healthcare providers and emergency medical services.
NASDAQ: MASS
This company develops handheld mass spectrometry devices for chemical and drug detection for public safety, defence, and law enforcement organisations.
The Smart Lollipop
This company develops a lollipop-shaped medical device for non-invasive saliva sample collection and biomarker detection to diagnose diseases in children and adults.
AUGURIX SA
This company develops and manufactures rapid point-of-care diagnostic tests for gastrointestinal diseases, specifically celiac disease, for patients and healthcare institutions.
